Error - Could not copy link. Try again
Page link copied
Weekly Round-up

Medicinal Cannabis Matters – Friday Roundup 27th September.

Medicinal Cannabis Matters | Friday roundup 27th September 2024.

Medicinal Cannabis Matters – Our weekly round-up of what has been happening in the world of medicinal cannabis this week. 

This week, we look at how medicinal cannabis has allowed one patient to find relief after a lifetime of pain, we look into a study about medicinal cannabis and its effects on the adult brain, and we also explore how medicinal cannabis has been recognised as a natural alternative for the treatment of neuropathic pain. 

Mum finds relief from Migraines after a lifetime of pain.

A Northern Ireland mother has found relief from Migraines by using medicinal cannabis after all other treatments failed. Toria Lyttle has battled with Migraines since her childhood, and medicinal cannabis has significantly improved her quality of life. 

Read more

Study Suggests Medical Cannabis “Brain-Safe” For Adults

A recent study has found adult medicinal cannabis patients do not experience any changes in brain morphology (form and structure) or cognitive performance after a year of regular use. Read more about the study by clicking the link below.

Learn more

Medicinal cannabis as a natural alternative for the management of neuropathic pain. 

Recently, cannabinoids have emerged as a natural treatment option for Neuropathic pain. The potential for medicinal cannabis as a treatment option is majorly overlooked due to the stigma around it, however, more research is taking place and more benefits are being discovered. 
Read more

If you’re interested in learning more about medicinal cannabis and how it can help you manage your condition, fill out the simple form linked below. Start your journey today with the only award-winning clinic in Jersey and Guernsey.

Check your eligibility. 

https://www.medicann.co.uk/book-consultation/eligibility

Disclaimer: 

This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.

Other articles